249 related articles for article (PubMed ID: 18279524)
1. Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems.
Wei MQ; Ren R; Good D; Anné J
Genet Vaccines Ther; 2008 Feb; 6():8. PubMed ID: 18279524
[TBL] [Abstract][Full Text] [Related]
2. Clostridial spores to treat solid tumours - potential for a new therapeutic modality.
Mengesha A; Wei JZ; Zhou SF; Wei MQ
Curr Gene Ther; 2010 Feb; 10(1):15-26. PubMed ID: 20158471
[TBL] [Abstract][Full Text] [Related]
3. The use of clostridial spores for cancer treatment.
Barbé S; Van Mellaert L; Anné J
J Appl Microbiol; 2006 Sep; 101(3):571-8. PubMed ID: 16907807
[TBL] [Abstract][Full Text] [Related]
4. Clostridial spores for cancer therapy: targeting solid tumour microenvironment.
Umer B; Good D; Anné J; Duan W; Wei MQ
J Toxicol; 2012; 2012():862764. PubMed ID: 22737166
[TBL] [Abstract][Full Text] [Related]
5. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic tumour targeting using clostridial spores.
Minton NP; Mauchline ML; Lemmon MJ; Brehm JK; Fox M; Michael NP; Giaccia A; Brown JM
FEMS Microbiol Rev; 1995 Oct; 17(3):357-64. PubMed ID: 7576773
[TBL] [Abstract][Full Text] [Related]
7. The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy.
Kubiak AM; Minton NP
Res Microbiol; 2015 May; 166(4):244-54. PubMed ID: 25576776
[TBL] [Abstract][Full Text] [Related]
8. Bacterial targeted tumour therapy-dawn of a new era.
Wei MQ; Mengesha A; Good D; Anné J
Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
[TBL] [Abstract][Full Text] [Related]
9. Viral-mediated gene transfer for cancer treatment.
Wilson DR
Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
[TBL] [Abstract][Full Text] [Related]
10. Use of bacteria in anti-cancer therapies.
Ryan RM; Green J; Lewis CE
Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
[TBL] [Abstract][Full Text] [Related]
11. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours.
Wei MQ; Ellem KA; Dunn P; West MJ; Bai CX; Vogelstein B
Eur J Cancer; 2007 Feb; 43(3):490-6. PubMed ID: 17113280
[TBL] [Abstract][Full Text] [Related]
12. The tumour-Clostridium phenomenon: 50 years of developmental research (Review).
Schmidt W; Fabricius EM; Schneeweiss U
Int J Oncol; 2006 Dec; 29(6):1479-92. PubMed ID: 17088987
[TBL] [Abstract][Full Text] [Related]
13. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy.
Osswald A; Sun Z; Grimm V; Ampem G; Riegel K; Westendorf AM; Sommergruber W; Otte K; Dürre P; Riedel CU
Microb Cell Fact; 2015 Dec; 14():199. PubMed ID: 26655167
[TBL] [Abstract][Full Text] [Related]
15. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
Wildner O; Morris JC
J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
[TBL] [Abstract][Full Text] [Related]
16. Siderophore-drug complexes: potential medicinal applications of the 'Trojan horse' strategy.
Górska A; Sloderbach A; Marszałł MP
Trends Pharmacol Sci; 2014 Sep; 35(9):442-9. PubMed ID: 25108321
[TBL] [Abstract][Full Text] [Related]
17. Human skin-derived fibroblasts used as a 'Trojan horse' for drug delivery.
Coccè V; Vitale A; Colombo S; Bonomi A; Sisto F; Ciusani E; Alessandri G; Parati E; Brambilla P; Brambilla M; La Porta CA; Pessina A
Clin Exp Dermatol; 2016 Jun; 41(4):417-24. PubMed ID: 26899383
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of
Sharafabad BE; Abdoli A; Abdolmohammadi Khiav L; Meskini M; Jamur P; Dilmaghani A
Curr Cancer Drug Targets; 2023; 23(9):682-696. PubMed ID: 37069721
[TBL] [Abstract][Full Text] [Related]
19. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
